Consolidated Balance Sheets - USD ($)	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Prepaid expense	$ 67,344	$ 6,325
Total current assets	67,344	6,325
Noncurrent assets
Marketable securities held in trust account	6,898,161	6,677,519
Total noncurrent assets	6,898,161	6,677,519
Total assets	6,965,505	6,683,844
Current liabilities:
Accrued expenses	455,455	400,286
Due to Sponsor	1,310,823	1,081,153
Promissory notes-related party	2,972,403	2,822,403
Total current liabilities	4,738,681	4,303,842
Noncurrent liabilities
Deferred underwriting commissions	2,875,000	2,875,000
Total noncurrent liabilities	2,875,000	2,875,000
Total liabilities	7,613,681	7,178,842
Commitments and contingencies (Note 6)
Ordinary shares subject to possible redemption, 552,451 and 552,451 shares at redemption value of $12.49 and $12.09 per share as of March 31, 2025 and December 31, 2024, respectively	6,898,161	6,677,519
Shareholders’ deficit:
Ordinary shares, par value $0.001, authorized 50,000,000 shares; 3,205,000 and 3,205,000 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively, excluding 552,451 and 552,451 shares subject to possible redemption at March 31, 2025 and December 31, 2024, respectively.	3,205	3,205
Accumulated deficit	(7,549,542)	(7,175,722)
Total shareholders’ deficit	(7,546,337)	(7,172,517)
Total liabilities, redeemable ordinary shares and shareholders’ deficit	$ 6,965,505	$ 6,683,844